Cas:83459-37-4 2,4-Dihydroxy-6-methoxy-3-methylacetophenone manufacturer & supplier

Chemical Name:2,4-Dihydroxy-6-methoxy-3-methylacetophenone

CAS.NO:83459-37-4

Synonyms:1-(2,4-Dihydroxy-6-methoxy-3-methylphenyl)ethanone;2,4-Dihydroxy-6-methoxy-3-methylacetophenone;Ethanone, 1-(2,4-dihydroxy-6-methoxy-3-methylphenyl)-;1-(2,4-Dihydroxy-6-methoxy-3-methyl-phenyl)-aethanon;1-(2,4-dihydroxy-6-methoxy-3-methyl-phenyl)-ethanone

Molecular Formula:C₁₀H₁₂O₄

Molecular Weight:196.200

HS Code:

Physical and Chemical Properties:

Melting point:224℃

Boiling point:355.5±22.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.566

PSA:66.76000

Exact Mass:196.073563

LogP:2.65

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(2,4-Dihydroxy-6-methoxy-3-methylphenyl)ethanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(2,4-dihydroxy-6-methoxy-3-methyl-phenyl)-ethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(2,4-Dihydroxy-6-methoxy-3-methylphenyl)ethanone Use and application,Ethanone, 1-(2,4-dihydroxy-6-methoxy-3-methylphenyl)- technical grade,usp/ep/jp grade.

Related News: In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances. 2,4-Dihydroxy-6-methoxy-3-methylacetophenone manufacturer f you’ve traveled in or transited through mainland China, you won’t be allowed into New Zealand unless you’re a New Zealand national. 2,4-Dihydroxy-6-methoxy-3-methylacetophenone supplier As part of the deal, CROS NT CEO Paolo Morelli becomes Alira’s executive vice president of biometrics. 2,4-Dihydroxy-6-methoxy-3-methylacetophenone vendor f you’ve traveled in or transited through mainland China, you won’t be allowed into New Zealand unless you’re a New Zealand national. 2,4-Dihydroxy-6-methoxy-3-methylacetophenone factory Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.